News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
This is What Happens When the FDA Approves Cancer Drugs Too Quickly     8/17/2017
Arcus Biosciences, Wuxi Biologics Hammer Out R&D Cancer Pact Worth $816 Million+     8/17/2017
Tiny Virtual Biotech CellAct Forges $250 Million Chemo R&D Pact With Mundipharma     8/15/2017
AstraZeneca PLC (AZN) Seals a $8.5 Billion R&D Cancer Tie-Up With Merck & Co. (MRK)     7/28/2017
Google (GOOG) Quietly Invests in This Cancer-Testing Startup, Builds Lab on Verily (GOOGL) Campus to Sweeten Deal     7/27/2017
5 Cancer Drugs That Will Become Even Bigger Winners by 2022     7/12/2017
Waiting Lists are Already Forming for Novartis AG (NVS) and Kite Pharma (KITE)'s Not-Yet Approved CAR-T Drugs     7/11/2017
Biotech Bestie Celgene (CELG) Takes Stake, Inks $1 Billion+ Deal With BeiGene (BGNE)     7/7/2017
Elephants Rarely Get Cancer and Why That’s Good News for Pet Owners and Us     6/28/2017
BIO2017: Eli Lilly (LLY) Clinical Development Head Looks to Innovate, Continue Alzheimer’s Research     6/21/2017
Bay Area Tech Titan Sean Parker Reaches Out to Unheard-Of Biotech to Confront Immunotherapy     6/20/2017
BIO2017: After IPO, Full Speed Ahead for San Diego’s Tocagen     6/20/2017
New Data Reveals This New York Biotech's Pipeline Could be a Game Changer     6/19/2017
Why Drug Giants Like Merck & Co. (MRK) and AstraZeneca PLC (AZN) Scientists are Looking in the Toilet for New Cancer Treatments     6/16/2017
Loxo Oncology (LOXO) Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It     6/8/2017

News from Around the Web
A New Heart Disease Test Flings Color Genomics Into A Battle About Genetics In Medicine     8/11/2017
Glowing Tumor Technology Helps Surgeons Remove Hidden Cancer Cells, University of Pennsylvania School of Medicine Reveals     7/28/2017
The Startling History Behind Merck & Co. (MRK)'s New Cancer Blockbuster     7/26/2017
Nanoparticles Loaded With Component Of Common Spice Kill Cancer Cells, Nanoscale Reveals     7/26/2017
The Problem With Saying John McCain Can 'Fight' His Cancer     7/25/2017
University of Pennsylvania Researchers Engineer Macrophages To Engulf Cancer Cells In Solid Tumors     7/20/2017
Top 10 Therapeutic Areas In Biopharma R&D     7/18/2017
Google (GOOG) Search Data Can Predict Cancer Incidence And Mortality     6/30/2017
Vaccine To Slow Cancer Growth Closer To Human Trials, University of Sydney Reveals     6/28/2017
Thwarting Metastasis By Breaking Cancer's Legs With Gold Rods, Georgia Institute of Technology Study     6/28/2017
The FDA Has Never Approved A Drug Like This In Its 111-Year History     6/27/2017
Using 'Sticky' Nanoparticles, Researchers Develop Strategy To Boost Body's Cancer Defenses, University of North Carolina Lineberger Comprehensive Cancer Center Study Reveals     6/27/2017
3 Must-Covet Cancer Biotech Stocks     6/20/2017
How Upcoming Mystic Data Will Be AstraZeneca PLC (AZN) CEO's Biggest Test     6/20/2017
While Amgen (AMGN)-Size Biotechs Run Into Trouble, These Are The Biotechs With The Most Promising Pipelines     6/19/2017

Press Releases
Cellectis (CLLS)’ UCART123 Administered To First Patient With BPDCN In Phase I Clinical Trial At MD Anderson Cancer Center     8/18/2017
A Plant Based Delivery System For Anti-Cancer Drugs, Published In Experimental Biology And Medicine     8/18/2017
Kite Pharma (KITE) Highlights Publication From The NCI Demonstrating Responses In Patients With Metastatic Solid Tumors Treated With T Cell Receptor (TCR) Therapy Targeting MAGE A3     8/17/2017
A New Heart Disease Test Flings Color Genomics Into A Battle About Genetics In Medicine     8/11/2017
Oasmia Receives Market Approval For Its Anti-Cancer Drug Doxophos In Russia     8/10/2017
WuXi AppTec Immunotherapy Report: Biotech Sector Will Drive Biggest Advancements In Decades On Cancer Treatments     8/10/2017
Detection Of Circulating Tumor Cells In Breast Cancer Patients Using The GILUPI CellCollector     8/9/2017
Novogen (NVGN) Release: Progress Update On Cantrixil (TRXE-002-1) Development     8/7/2017
Enzychem Lifesciences, Corp's Investigational New Drug Application (IND) For Chemoradiation Induced Oral Mucositis Had Been Granted By The FDA     8/3/2017
FDA Grants Genentech (RHHBY)’s Alecensa Priority Review For Initial Treatment Of People With ALK-Positive Lung Cancer     8/3/2017
Oncotherm Release: Saudi Arabia Approves Oncothermia, The Latest Technology In Cancer Treatment     8/3/2017
Mauna Kea Technologies Announces Peer-Reviewed Publication Of Key Multicenter Randomized Controlled Trial Demonstrating Improved Early Stomach Cancer Detection With Cellvizio     8/3/2017
Saphetor SA And Supratech Leverage Genome Scale Analyses To Facilitate Precision Oncology Treatments     8/3/2017
Edico Genome Signs Contracts With National Human Genome Research Institute And NCI For Use Of DRAGEN For Cancer Research     8/2/2017
PellePharm, Inc Announces Topline Results From Phase II Study Of Topical Patidegib In Gorlin Syndrome Basal Cell Carcinomas And Third Closing Of A $20 Million Series B Financing     7/31/2017